Barreca ML - Search Results

1

New pyrazolobenzothiazine derivatives as hepatitis C virus NS5B polymerase palm site I inhibitors.

Manfroni G, Manvar D, Barreca ML, Kaushik-Basu N, Leyssen P, Paeshuyse J, Cannalire R, Iraci N, Basu A, Chudaev M, Zamperini C, Dreassi E, Sabatini S, Tabarrini O, Neyts J, Cecchetti V. Manfroni G, et al. Among authors: barreca ml. J Med Chem. 2014 Apr 24;57(8):3247-62. doi: 10.1021/jm401688h. Epub 2014 Apr 2. J Med Chem. 2014. PMID: 24654886 Free PMC article.

2

Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs).

Barreca ML, Carotti A, Carrieri A, Chimirri A, Monforte AM, Calace MP, Rao A. Barreca ML, et al. Bioorg Med Chem. 1999 Nov;7(11):2283-92. doi: 10.1016/s0968-0896(99)00181-9. Bioorg Med Chem. 1999. PMID: 10632038

3

Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents.

Barreca ML, Chimirri A, De Luca L, Monforte AM, Monforte P, Rao A, Zappalà M, Balzarini J, De Clercq E, Pannecouque C, Witvrouw M. Barreca ML, et al. Bioorg Med Chem Lett. 2001 Jul 9;11(13):1793-6. doi: 10.1016/s0960-894x(01)00304-3. Bioorg Med Chem Lett. 2001. PMID: 11425562

4

Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents.

Barreca ML, Balzarini J, Chimirri A, De Clercq E, De Luca L, Höltje HD, Höltje M, Monforte AM, Monforte P, Pannecouque C, Rao A, Zappalà M. Barreca ML, et al. J Med Chem. 2002 Nov 21;45(24):5410-3. doi: 10.1021/jm020977+. J Med Chem. 2002. PMID: 12431069

5

Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist.

Gitto R, Barreca ML, De Luca L, De Sarro G, Ferreri G, Quartarone S, Russo E, Constanti A, Chimirri A. Gitto R, et al. Among authors: barreca ml. J Med Chem. 2003 Jan 2;46(1):197-200. doi: 10.1021/jm0210008. J Med Chem. 2003. PMID: 12502375

6

QSAR study of anticonvulsant negative allosteric modulators of the AMPA receptor.

Macchiarulo A, De Luca L, Costantino G, Barreca ML, Gitto R, Pellicciari R, Chimirri A. Macchiarulo A, et al. Among authors: barreca ml. J Med Chem. 2004 Mar 25;47(7):1860-3. doi: 10.1021/jm0310838. J Med Chem. 2004. PMID: 15027880

7

Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT.

Barreca ML, Rao A, De Luca L, Zappalà M, Monforte AM, Maga G, Pannecouque C, Balzarini J, De Clercq E, Chimirri A, Monforte P. Barreca ML, et al. J Med Chem. 2005 May 5;48(9):3433-7. doi: 10.1021/jm049279a. J Med Chem. 2005. PMID: 15857150

8

5-Arylidene-2-imino-4-thiazolidinones: design and synthesis of novel anti-inflammatory agents.

Ottanà R, Maccari R, Barreca ML, Bruno G, Rotondo A, Rossi A, Chiricosta G, Di Paola R, Sautebin L, Cuzzocrea S, Vigorita MG. Ottanà R, et al. Among authors: barreca ml. Bioorg Med Chem. 2005 Jul 1;13(13):4243-52. doi: 10.1016/j.bmc.2005.04.058. Bioorg Med Chem. 2005. PMID: 15905093

9

Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors.

Barreca ML, Ferro S, Rao A, De Luca L, Zappalà M, Monforte AM, Debyser Z, Witvrouw M, Chimirri A. Barreca ML, et al. J Med Chem. 2005 Nov 3;48(22):7084-8. doi: 10.1021/jm050549e. J Med Chem. 2005. PMID: 16250669

10

Binding mode prediction of strand transfer HIV-1 integrase inhibitors using Tn5 transposase as a plausible surrogate model for HIV-1 integrase.

Barreca ML, De Luca L, Iraci N, Chimirri A. Barreca ML, et al. J Med Chem. 2006 Jun 29;49(13):3994-7. doi: 10.1021/jm060323r. J Med Chem. 2006. PMID: 16789757

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102 results

Search Page